Xeris Biopharma Holdings (XERS) Prepaid Assets (2020 - 2026)

Xeris Biopharma Holdings has reported Prepaid Assets for 7 years, with the latest figure at $9.4 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 55.83% year-over-year to $9.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (up 55.83% YoY), and the FY2025 full-year result was $9.5 million, up 28.14% from the prior year.
• Prepaid Assets for Q1 2026 stood at $9.4 million, down from $9.5 million in the prior quarter.
• The five-year high for Prepaid Assets was $11.2 million in Q3 2025, with the low at $5.1 million in Q1 2022.
• Historically, Prepaid Assets has averaged $7.8 million across 5 years, with a median of $7.6 million in 2024.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 119.07% — and 2023, when it tumbled 37.78%.
• Xeris Biopharma Holdings' Prepaid Assets stood at $9.3 million in 2022, then sank by 37.78% to $5.8 million in 2023, then increased by 28.95% to $7.5 million in 2024, then advanced by 28.14% to $9.5 million in 2025, then dropped by 1.52% to $9.4 million in 2026.
• The last three Prepaid Assets figures came in at $9.4 million (Q1 2026), $9.5 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.